Skip to main content
OpenTrials
Completed

NCT Number: NCT04720625

Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers

The goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smoking. This Adapt2Quit system will be compared with a quitline facilitation-only control (text messages will be sent to facilitate quitline use). The primary research hypothesis is that the Adapt2Quit recommender-selected messages will be more effective than a texting quitline facilitation-only control for smoking cessation among socioeconomically disadvantaged (SED) smokers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Smoking Behavior Smoking Tobacco Use

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Johns Hopkins University, Baltimore, Maryland, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current smoker
  • Socioeconomically disadvantaged (SED) (using the following criteria: unemployed or underemployed, low income as defined by the federal poverty level guidelines, uninsured or underinsured, and/or have less than a high school education)
  • English-speaking
  • Active in care (at least two clinical visits in the last year)
  • Have a texting-enabled cell phone

Exclusion criteria

  • Not a current smoker
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Prisoners
  • Pregnant women
  • Pilot study participants

Treatment and study plan

Adapt2Quit

Behavioral

Motivational text messages and quitline facilitation text messages will be sent to participants; these participants will receive Adapt2Quit (experimental) messages as well as quitline facilitation messages.

Control

Behavioral

Quitline facilitation text messages will be sent to participants; these participants will receive quitline facilitation-only messages.

Primary outcomes

  1. Self-Reported Participant Tobacco Cessation Rate (quit rate)

    Time frame: 6-months post-randomization

    Self-reported 6-month point prevalence cessation (yes/no) will be assessed at 6-month follow-up.

  2. Biochemical Carbon Monoxide (CO) Verification of Tobacco Cessation

    Time frame: 6-months post-randomization

    Biochemical carbon monoxide (CO) verification testing will also be done for a small subset of participants, where 0-6 parts per million (PPM) measures a non-smoker and 7+ PPM indicates a current smoker.

Secondary outcomes

  1. Time to First Quit Attempt

    Time frame: From randomization to 6-months post-randomization

    Self-reported date of first quit attempt since starting the study will be assessed through text message response from participant during the 6-month intervention period.

Sponsors and collaborators

Lead sponsor

University of Massachusetts, Worcester

Other

Collaborators

  • Baystate Health
  • Johns Hopkins University
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Official study title

Adapt2Quit - A Machine-Learning, Adaptive Motivational System: RCT for Socio-Economically Disadvantaged Smokers

Acronym: A2Q

Important dates

Study start
2021
Primary completion
2024
Study completion
2025
First posted
Jan 22, 2021
Registry last updated
May 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.